Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the CM-1500
Primary Purpose
Fluid Loss, Blood Loss
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Whole blood donation supine
Whole blood donation reclined
Sponsored by
About this trial
This is an interventional diagnostic trial for Fluid Loss
Eligibility Criteria
Inclusion Criteria: Ability to provide written informed consent Ability and willingness to comply with the study procedures and duration requirements 18 years of age or older Consented and eligible to undergo a single unit whole blood donation Exclusion Criteria: Females who are pregnant or breastfeeding Undergone an amputation of any upper extremity Diagnosed with dextrocardia Subjects who have a pacemaker Subjects with body hair density which prevents adequate application of device electrodes
Sites / Locations
- SunCoast Blood CentersRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Supine Donation Position
Reclined Donation Position
Arm Description
Outcomes
Primary Outcome Measures
Impact of subject positioning on percent change of physiological parameters during minor blood loss
Percent change in heart rate, forearm skin temperature, bioelectrical impedance, ECG amplitude and PPG amplitude before and after blood draw in either a reclined or supine position.
Secondary Outcome Measures
Full Information
NCT ID
NCT05980013
First Posted
July 26, 2023
Last Updated
September 12, 2023
Sponsor
Zynex Monitoring Solutions
1. Study Identification
Unique Protocol Identification Number
NCT05980013
Brief Title
Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the CM-1500
Official Title
Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the Zynex Cardiac Monitor, Model 1500 (CM-1500)
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 28, 2023 (Actual)
Primary Completion Date
December 22, 2023 (Anticipated)
Study Completion Date
January 22, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zynex Monitoring Solutions
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study is a prospective, non-randomized, non-blinded, non-significant risk study enrolling up to 60 healthy adult subjects consented to undergo a 1-unit whole blood draw procedure. Subjects will wear the study device (CM-1500) while positioned in either a supine or reclined position during the blood draw and study-required physiological parameters will be captured pre-, during, and post-donation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fluid Loss, Blood Loss
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Supine Donation Position
Arm Type
Experimental
Arm Title
Reclined Donation Position
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Whole blood donation supine
Intervention Description
Subjects will undergo a 1-unit whole blood donation in a supine position
Intervention Type
Device
Intervention Name(s)
Whole blood donation reclined
Intervention Description
Subjects will undergo a 1-unit whole blood donation in a reclined position
Primary Outcome Measure Information:
Title
Impact of subject positioning on percent change of physiological parameters during minor blood loss
Description
Percent change in heart rate, forearm skin temperature, bioelectrical impedance, ECG amplitude and PPG amplitude before and after blood draw in either a reclined or supine position.
Time Frame
At completion of blood draw
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Ability to provide written informed consent
Ability and willingness to comply with the study procedures and duration requirements
18 years of age or older
Consented and eligible to undergo a single unit whole blood donation
Exclusion Criteria:
Females who are pregnant or breastfeeding
Undergone an amputation of any upper extremity
Diagnosed with dextrocardia
Subjects who have a pacemaker
Subjects with body hair density which prevents adequate application of device electrodes
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kristin Andrud, PhD
Phone
(800) 495-6670
Ext
3457
Email
kandrud@zynex.com
Facility Information:
Facility Name
SunCoast Blood Centers
City
Bradenton
State/Province
Florida
ZIP/Postal Code
34211
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shelley Harkey
Phone
941-954-1600
Ext
10141
Email
sharkey@suncoastblood.org
First Name & Middle Initial & Last Name & Degree
Debra Smith, MD, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the CM-1500
We'll reach out to this number within 24 hrs